米拉贝隆缓释片说明书.pdfVIP

  • 123
  • 0
  • 约7.02万字
  • 约 23页
  • 2020-02-28 发布于江苏
  • 举报
HIGHLIGHTS OF PRESCRIBING INFORMATION  Patients Taking Drugs Metabolized by CYP2D6 : Myrbetriq is a moderate These highlights do not include all the information needed to use inhibitor of CYP2D6. Appropriate monitoring is recommended and dose MYRBETRIQTM safely and effectively. See full prescribing information adjustment may be necessary for narrow therapeutic index CYP2D6 for MYRBETRIQ.

文档评论(0)

1亿VIP精品文档

相关文档